ArticleThe Journal of urology2024

Letter: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone‒Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist.

Jordi Stira et al.PubMed ↗Publisher ↗

No numbers read from the abstract.